e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Terumo Corp ADR
(OP:
TRUMY
)
14.06
-0.24 (-1.68%)
Streaming Delayed Price
Updated: 3:26 PM EST, Jan 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
325,191
Open
14.07
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
14.30
Today's Range
14.05 - 14.15
52wk Range
13.82 - 20.18
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition
Today 11:32 EST
MARLBOROUGH, MA – In a move that has sent shockwaves through the medical device sector, Boston Scientific Corporation (NYSE:BSX) announced today, January 15, 2026, a definitive agreement to acquire...
Via
MarketMinute
Topics
Artificial Intelligence
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
↗
January 23, 2024
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.
Via
Benzinga
Performance
YTD
-3.4%
-3.4%
1 Month
-4.5%
-4.5%
3 Month
-14.9%
-14.9%
6 Month
-14.5%
-14.5%
1 Year
-25.6%
-25.6%
More News
Read More
Why Shares of Orchestra BioMed Jumped Tuesday
↗
September 19, 2023
Via
The Motley Fool
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
March 01, 2023
Via
TheNewswire.com
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
March 01, 2023
Via
News Direct
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
↗
March 01, 2023
Via
Benzinga
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
↗
February 15, 2023
Via
Benzinga
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
January 17, 2023
Via
TheNewswire.com
Topics
Economy
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
January 17, 2023
Via
News Direct
Topics
Economy
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
↗
January 17, 2023
Via
Benzinga
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry
↗
January 09, 2023
Via
Benzinga
Inspira Technologies, The Company That Aims To Change 50 Years Of Therapeutic Paradigm In Patients With Respiratory Failure
↗
March 07, 2022
Via
Benzinga
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
January 12, 2023
Via
FinancialNewsMedia
Frequently Asked Questions
Is Terumo Corp ADR publicly traded?
Yes, Terumo Corp ADR is publicly traded.
What exchange does Terumo Corp ADR trade on?
Terumo Corp ADR trades on the OTC Traded
What is the ticker symbol for Terumo Corp ADR?
The ticker symbol for Terumo Corp ADR is TRUMY on the OTC Traded
What is the current price of Terumo Corp ADR?
The current price of Terumo Corp ADR is 14.06
When was Terumo Corp ADR last traded?
The last trade of Terumo Corp ADR was at 01/15/26 03:26 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.